Charles River Laboratories (CRL)
Solvency ratios
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial leverage ratio | 2.17 | 2.12 | 2.14 | 2.24 | 2.28 | 2.30 | 2.39 | 2.48 | 2.55 | 2.81 | 2.84 | 2.71 | 2.77 | 2.91 | 2.90 | 2.66 | 2.60 | 2.75 | 2.99 | 3.15 |
Based on the provided data, Charles River Laboratories consistently maintains a strong solvency position as indicated by its low debt-to-assets, debt-to-capital, and debt-to-equity ratios, all of which have been reported as 0.00 throughout the analyzed period up to December 31, 2024.
The financial leverage ratio, which measures the extent to which the company relies on debt financing, has shown a decreasing trend over the years, from 3.15 on March 31, 2020, to 2.17 on December 31, 2024. This declining trend indicates that Charles River Laboratories has been gradually reducing its financial leverage and becoming less reliant on debt to finance its operations and investments.
Overall, the solvency ratios suggest that Charles River Laboratories has a conservative approach to managing its debt levels and maintaining a healthy balance sheet structure, which is essential for ensuring financial stability and resilience in the long term.
Coverage ratios
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest coverage | 1.85 | 4.88 | 4.96 | 4.95 | 5.21 | 5.44 | 6.38 | 8.58 | 11.40 | 15.83 | 13.99 | 10.65 | 7.40 | 6.06 | 6.07 | 5.50 | 6.16 | 5.89 | 5.92 | 5.42 |
The interest coverage ratio of Charles River Laboratories has shown fluctuations over the past few years, ranging from a low of 1.85 at the end of December 2024 to a high of 15.83 at the end of September 2022. This ratio measures the company's ability to meet its interest obligations with its operating income, with higher ratios indicating a stronger ability to cover interest expenses.
The trend in the interest coverage ratio indicates variability in the company's ability to cover its interest expenses over time. A declining trend in the ratio suggests potentially increasing financial risk, as the company's ability to cover interest payments may be weakening. On the other hand, an increasing trend in the ratio demonstrates improved financial health and a stronger ability to meet interest obligations.
It is important for investors and stakeholders to closely monitor the interest coverage ratio of Charles River Laboratories to assess its financial stability and ability to manage debt effectively. Fluctuations in the ratio could signal changes in the company's financial performance and overall risk profile.